Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica

Background Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associa...

Full description

Saved in:
Bibliographic Details
Published inRespiratory research Vol. 17; no. 1; p. 160
Main Authors Zelko, Igor N., Zhu, Jianxin, Ritzenthaler, Jeffrey D., Roman, Jesse
Format Journal Article
LanguageEnglish
Published London BioMed Central 28.11.2016
BioMed Central Ltd
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN1465-993X
1465-9921
1465-993X
DOI10.1186/s12931-016-0478-5

Cover

Abstract Background Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling. Methods C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology. Results Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated. Conclusions We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling.
AbstractList Background Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling. Methods C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology. Results Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated. Conclusions We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling.
Background Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling. Methods C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology. Results Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated. Conclusions We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling.
Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling. C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology. Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-[alpha] and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated. We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling.
Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling.BACKGROUNDOccupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling.C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology.METHODSC57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology.Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated.RESULTSMice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated.We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling.CONCLUSIONSWe characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling.
Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling. C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology. Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated. We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling.
Background Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling. Methods C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology. Results Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-[alpha] and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated. Conclusions We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling. Keywords: Silicosis, Pulmonary hypertension, Vascular remodeling, Animal model
ArticleNumber 160
Audience Academic
Author Zelko, Igor N.
Ritzenthaler, Jeffrey D.
Zhu, Jianxin
Roman, Jesse
Author_xml – sequence: 1
  givenname: Igor N.
  surname: Zelko
  fullname: Zelko, Igor N.
  email: igor.zelko@louisville.edu
  organization: Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Louisville, Department of Biochemisry and Molecular Genetics, University of Louisville
– sequence: 2
  givenname: Jianxin
  surname: Zhu
  fullname: Zhu, Jianxin
  organization: Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Louisville
– sequence: 3
  givenname: Jeffrey D.
  surname: Ritzenthaler
  fullname: Ritzenthaler, Jeffrey D.
  organization: Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Louisville
– sequence: 4
  givenname: Jesse
  surname: Roman
  fullname: Roman, Jesse
  organization: Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Louisville, Robley Rex VA Medical Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27894297$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1rFTEUhoNU7If-ADcScONmaj4nyUYoxS8o6KKCuxAzZ25TMsk1mSm9_95cbqu3RSWLhOR53_Cec47RQcoJEHpJySmlun9bKTOcdoT2HRFKd_IJOqKil50x_PvB3vkQHdd6TQhVWsln6JApbQQz6ghdfl3ilJMrG3y1WUOZIdWQE3ZpwDeu-iW6ggtMeYAY0gqHhKfgAcPtOlcY8JyxL5s6u9ieAdcQg3fP0dPRxQov7vYT9O3D-8vzT93Fl4-fz88uOt8TPnfUC5BKCC2kHkA445kBDpyD9NIMowLeeyCGaS4HIvzAJTPSC2O0Z9L1_AS92_mulx8TDB7SXFy06xKmFshmF-zDlxSu7CrfWElZrwVpBm_uDEr-uUCd7RSqhxhdgrxUS7UQPVFc6Ya-foRe56WkFm9L9UxoKugfauUi2JDG3P71W1N7JhQjgirBG3X6F6qtAVpxW4_H0O4fCF7tB_2d8L6PDVA7wJdca4HR-jC7uXWyOYdoKbHbibG7ibFtYux2YqxsSvpIeW_-Pw3baWpj0wrKXi3-KfoF7sjSJA
CitedBy_id crossref_primary_10_1177_2045894021996574
crossref_primary_10_3892_etm_2017_5160
crossref_primary_10_1371_journal_pone_0180724
crossref_primary_10_31089_1026_9428_2021_61_6_365_370
crossref_primary_10_1126_sciadv_adl4913
crossref_primary_10_1165_rcmb_2022_0056OC
crossref_primary_10_1080_08958378_2024_2413373
crossref_primary_10_1186_s12931_019_1018_x
crossref_primary_10_1007_s11596_019_2073_8
crossref_primary_10_7759_cureus_35425
crossref_primary_10_1007_s10787_022_01042_7
crossref_primary_10_1038_s41401_021_00693_6
crossref_primary_10_4081_monaldi_2023_2719
crossref_primary_10_1097_MD_0000000000009469
crossref_primary_10_1016_j_biopha_2017_08_126
crossref_primary_10_1093_rheumatology_keab118
crossref_primary_10_3390_ijms25147654
crossref_primary_10_1097_FJC_0000000000001156
crossref_primary_10_1186_s12931_018_0933_6
crossref_primary_10_1186_s12931_021_01832_7
crossref_primary_10_31089_1026_9428_2021_61_5_318_323
crossref_primary_10_1016_j_taap_2020_115242
crossref_primary_10_31089_1026_9428_2021_61_3_161_167
crossref_primary_10_1002_jbt_23071
crossref_primary_10_1016_j_jvc_2021_06_005
crossref_primary_10_3389_fneur_2024_1428625
crossref_primary_10_1016_j_taap_2020_115281
crossref_primary_10_1007_s11259_023_10106_0
crossref_primary_10_1016_j_taap_2022_116071
crossref_primary_10_1136_oemed_2021_108095
crossref_primary_10_1016_j_toxlet_2021_09_014
crossref_primary_10_1016_j_rmcr_2021_101522
crossref_primary_10_1016_j_ecoenv_2022_114100
crossref_primary_10_1186_s12989_020_00345_3
crossref_primary_10_1016_j_cbi_2023_110510
crossref_primary_10_1136_bmjopen_2023_078992
Cites_doi 10.1016/j.healun.2012.11.014
10.1186/s12933-014-0119-6
10.1016/j.jvir.2010.02.030
10.1164/ajrccm.157.5.9707141
10.1093/aje/kwt139
10.1182/blood.V98.5.1456
10.1016/S0272-5231(05)70282-3
10.1097/00003246-199811000-00031
10.1007/BF02714139
10.1161/01.RES.87.5.418
10.1016/S0140-6736(95)90173-6
10.1183/09031936.01.00084601
10.1183/09031936.05.00072504
10.1182/blood.V97.6.1727
10.1378/chest.129.3.746
10.1126/science.1156995
10.1164/ajrccm.158.3.9709103
10.1002/ajim.20986
10.4049/jimmunol.157.3.1233
10.1183/13993003.00574-2015
10.1097/ACI.0b013e32802bf8a5
10.1016/j.ajpath.2013.01.010
10.1093/cvr/cvm102
10.1152/ajpheart.00254.2009
10.1023/A:1015967017103
10.1055/s-2004-831051
10.1136/oem.60.4.237
10.1164/ajrccm.164.9.2101036
10.1136/oem.58.1.31
10.1093/bmb/lds028
10.1152/jappl.1991.71.5.2012
ContentType Journal Article
Copyright The Author(s). 2016
COPYRIGHT 2016 BioMed Central Ltd.
Copyright BioMed Central 2016
Copyright_xml – notice: The Author(s). 2016
– notice: COPYRIGHT 2016 BioMed Central Ltd.
– notice: Copyright BioMed Central 2016
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7U7
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOI 10.1186/s12931-016-0478-5
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Toxicology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database ProQuest
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
Toxicology Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database

MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1465-993X
ExternalDocumentID PMC5126840
4271136331
A472041743
27894297
10_1186_s12931_016_0478_5
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: National Institute on Alcohol Abuse and Alcoholism
  grantid: R01 AA019953
  funderid: http://dx.doi.org/10.13039/100000027
– fundername: Research Incentive Grant from UofL School of Medicine
– fundername: National Heart, Lung, and Blood Institute
  grantid: R56HL128597
  funderid: http://dx.doi.org/10.13039/100000050
– fundername: BLRD VA
  grantid: I01 BX000216
– fundername: NHLBI NIH HHS
  grantid: R56 HL128597
– fundername: NIAAA NIH HHS
  grantid: R01 AA019953
– fundername: ;
– fundername: ;
  grantid: R01 AA019953
– fundername: ;
  grantid: R56HL128597
GroupedDBID ---
0R~
29P
2WC
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
KQ8
M1P
M48
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RIG
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7QL
7U7
7U9
7XB
8FK
AZQEC
C1K
DWQXO
H94
K9.
M7N
PKEHL
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c603t-1c4e57448458de4a9c29e3e33e5c59df7e36ce092835d04cd35295c4998c25a63
IEDL.DBID M48
ISSN 1465-993X
1465-9921
IngestDate Thu Aug 21 13:55:13 EDT 2025
Fri Sep 05 04:22:27 EDT 2025
Thu Sep 18 13:10:47 EDT 2025
Tue Jun 17 22:05:45 EDT 2025
Tue Jun 10 21:05:09 EDT 2025
Thu Apr 03 07:03:42 EDT 2025
Tue Jul 01 02:43:09 EDT 2025
Thu Apr 24 23:08:47 EDT 2025
Sat Sep 06 07:29:01 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Vascular remodeling
Animal model
Silicosis
Pulmonary hypertension
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c603t-1c4e57448458de4a9c29e3e33e5c59df7e36ce092835d04cd35295c4998c25a63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doi.org/10.1186/s12931-016-0478-5
PMID 27894297
PQID 1846248141
PQPubID 42864
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5126840
proquest_miscellaneous_1844607378
proquest_journals_1846248141
gale_infotracmisc_A472041743
gale_infotracacademiconefile_A472041743
pubmed_primary_27894297
crossref_citationtrail_10_1186_s12931_016_0478_5
crossref_primary_10_1186_s12931_016_0478_5
springer_journals_10_1186_s12931_016_0478_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-11-28
PublicationDateYYYYMMDD 2016-11-28
PublicationDate_xml – month: 11
  year: 2016
  text: 2016-11-28
  day: 28
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Respiratory research
PublicationTitleAbbrev Respir Res
PublicationTitleAlternate Respir Res
PublicationYear 2016
Publisher BioMed Central
BioMed Central Ltd
Nature Publishing Group
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Nature Publishing Group
References E Frisdal (478_CR27) 2001; 18
F Saboor (478_CR35) 2016; 47
A Seaton (478_CR10) 1995; 345
GS Davis (478_CR16) 1998; 17
J Wright (478_CR20) 1991; 169
R Jandova (478_CR13) 1980; 22
V Castranova (478_CR5) 2002; 234–235
A Nemmar (478_CR9) 2001; 164
J Schmeck (478_CR22) 1998; 26
E Hnizdo (478_CR1) 2003; 60
TJ McMahon (478_CR23) 1985; 71
Y Rival (478_CR31) 1996; 157
J Carlsen (478_CR14) 2013; 32
F Huaux (478_CR6) 2007; 7
S Honnons (478_CR17) 2000; 19
JM Hughes (478_CR4) 1998; 158
DD Landen (478_CR11) 2011; 54
C Dostert (478_CR7) 2008; 320
M Rabinovitch (478_CR29) 2001; 22
BT Mossman (478_CR8) 1998; 157
DP Hajjar (478_CR24) 2013; 182
K Tardif (478_CR34) 2014; 13
S Patil (478_CR33) 2001; 97
W Chen (478_CR18) 2001; 58
KL Jones (478_CR32) 2001; 98
R Rajkumar (478_CR36) 2010; 298
A Hyduk (478_CR12) 2005; 54
SN Hu (478_CR19) 1990; 114
A Vieillard-Baron (478_CR30) 2000; 87
CJ Lettieri (478_CR15) 2006; 129
S Misra (478_CR28) 2010; 21
H Lepetit (478_CR26) 2005; 25
PD McGavran (478_CR21) 1990; 136
P Cullinan (478_CR3) 2012; 104
VW van Hinsbergh (478_CR25) 2008; 78
A Bikfalvi (478_CR37) 2004; 30
Y Liu (478_CR2) 2013; 178
16280974 - MMWR Surveill Summ. 2005 Nov 11;54(5):1-28
15282661 - Semin Thromb Hemost. 2004 Jun;30(3):379-85
1849213 - Lung. 1991;169(1):31-42
11213022 - J Environ Pathol Toxicol Oncol. 2000;19(4):391-400
11757635 - Eur Respir J. 2001 Nov;18(5):838-45
18403674 - Science. 2008 May 2;320(5876):674-7
11590839 - Clin Chest Med. 2001 Sep;22(3):433-49, viii
21761428 - Am J Ind Med. 2011 Oct;54(10):727-33
9731009 - Am J Respir Crit Care Med. 1998 Sep;158(3):807-14
1837015 - J Appl Physiol (1985). 1991 Nov;71(5):2012-8
9546745 - J Environ Pathol Toxicol Oncol. 1998;17(2):81-97
23265910 - J Heart Lung Transplant. 2013 Mar;32(3):347-54
17351471 - Curr Opin Allergy Clin Immunol. 2007 Apr;7(2):168-73
16537877 - Chest. 2006 Mar;129(3):746-52
2156434 - Am J Pathol. 1990 Mar;136(3):695-705
9824081 - Crit Care Med. 1998 Nov;26(11):1868-74
11719307 - Am J Respir Crit Care Med. 2001 Nov 1;164(9):1665-8
10969041 - Circ Res. 2000 Sep 1;87(5):418-25
7741860 - Lancet. 1995 Jan 21;345(8943):176-8
12162431 - Mol Cell Biochem. 2002 May-Jun;234-235(1-2):177-84
25139503 - Cardiovasc Diabetol. 2014 Aug 21;13:119
8757631 - J Immunol. 1996 Aug 1;157(3):1233-41
2145819 - Arch Pathol Lab Med. 1990 Oct;114(10):1063-70
20081107 - Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1235-48
12660371 - Occup Environ Med. 2003 Apr;60(4):237-43
18079100 - Cardiovasc Res. 2008 May 1;78(2):203-12
9603153 - Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1666-80
24043436 - Am J Epidemiol. 2013 Nov 1;178(9):1424-33
20434368 - J Vasc Interv Radiol. 2010 Jun;21(6):896-902
11520795 - Blood. 2001 Sep 1;98(5):1456-63
23608224 - Am J Pathol. 2013 May;182(5):1474-81
15863640 - Eur Respir J. 2005 May;25(5):834-42
26699726 - Eur Respir J. 2016 Mar;47(3):876-88
23080418 - Br Med Bull. 2012;104:143-61
11119632 - Occup Environ Med. 2001 Jan;58(1):31-7
11238114 - Blood. 2001 Mar 15;97(6):1727-32
7449392 - Cor Vasa. 1980;22(4):221-37
References_xml – volume: 32
  start-page: 347
  year: 2013
  ident: 478_CR14
  publication-title: J Heart Lung Transplant
  doi: 10.1016/j.healun.2012.11.014
– volume: 13
  start-page: 119
  year: 2014
  ident: 478_CR34
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-014-0119-6
– volume: 21
  start-page: 896
  year: 2010
  ident: 478_CR28
  publication-title: J Vasc Interv Radiol
  doi: 10.1016/j.jvir.2010.02.030
– volume: 157
  start-page: 1666
  year: 1998
  ident: 478_CR8
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.157.5.9707141
– volume: 54
  start-page: 1
  year: 2005
  ident: 478_CR12
  publication-title: MMWR Surveill Summ
– volume: 178
  start-page: 1424
  year: 2013
  ident: 478_CR2
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwt139
– volume: 98
  start-page: 1456
  year: 2001
  ident: 478_CR32
  publication-title: Blood
  doi: 10.1182/blood.V98.5.1456
– volume: 22
  start-page: 433
  year: 2001
  ident: 478_CR29
  publication-title: Clin Chest Med
  doi: 10.1016/S0272-5231(05)70282-3
– volume: 26
  start-page: 1868
  year: 1998
  ident: 478_CR22
  publication-title: Crit Care Med
  doi: 10.1097/00003246-199811000-00031
– volume: 169
  start-page: 31
  year: 1991
  ident: 478_CR20
  publication-title: Lung
  doi: 10.1007/BF02714139
– volume: 87
  start-page: 418
  year: 2000
  ident: 478_CR30
  publication-title: Circ Res
  doi: 10.1161/01.RES.87.5.418
– volume: 345
  start-page: 176
  year: 1995
  ident: 478_CR10
  publication-title: Lancet
  doi: 10.1016/S0140-6736(95)90173-6
– volume: 18
  start-page: 838
  year: 2001
  ident: 478_CR27
  publication-title: Eur Respir J
  doi: 10.1183/09031936.01.00084601
– volume: 19
  start-page: 391
  year: 2000
  ident: 478_CR17
  publication-title: J Environ Pathol Toxicol Oncol
– volume: 25
  start-page: 834
  year: 2005
  ident: 478_CR26
  publication-title: Eur Respir J
  doi: 10.1183/09031936.05.00072504
– volume: 97
  start-page: 1727
  year: 2001
  ident: 478_CR33
  publication-title: Blood
  doi: 10.1182/blood.V97.6.1727
– volume: 136
  start-page: 695
  year: 1990
  ident: 478_CR21
  publication-title: Am J Pathol
– volume: 129
  start-page: 746
  year: 2006
  ident: 478_CR15
  publication-title: Chest
  doi: 10.1378/chest.129.3.746
– volume: 320
  start-page: 674
  year: 2008
  ident: 478_CR7
  publication-title: Science
  doi: 10.1126/science.1156995
– volume: 158
  start-page: 807
  year: 1998
  ident: 478_CR4
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.158.3.9709103
– volume: 54
  start-page: 727
  year: 2011
  ident: 478_CR11
  publication-title: Am J Ind Med
  doi: 10.1002/ajim.20986
– volume: 157
  start-page: 1233
  year: 1996
  ident: 478_CR31
  publication-title: J Immunol
  doi: 10.4049/jimmunol.157.3.1233
– volume: 47
  start-page: 876
  year: 2016
  ident: 478_CR35
  publication-title: Eur Respir J
  doi: 10.1183/13993003.00574-2015
– volume: 7
  start-page: 168
  year: 2007
  ident: 478_CR6
  publication-title: Curr Opin Allergy Clin Immunol
  doi: 10.1097/ACI.0b013e32802bf8a5
– volume: 182
  start-page: 1474
  year: 2013
  ident: 478_CR24
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2013.01.010
– volume: 22
  start-page: 221
  year: 1980
  ident: 478_CR13
  publication-title: Cor Vasa
– volume: 78
  start-page: 203
  year: 2008
  ident: 478_CR25
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvm102
– volume: 114
  start-page: 1063
  year: 1990
  ident: 478_CR19
  publication-title: Arch Pathol Lab Med
– volume: 298
  start-page: H1235
  year: 2010
  ident: 478_CR36
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00254.2009
– volume: 17
  start-page: 81
  year: 1998
  ident: 478_CR16
  publication-title: J Environ Pathol Toxicol Oncol
– volume: 234–235
  start-page: 177
  year: 2002
  ident: 478_CR5
  publication-title: Mol Cell Biochem
  doi: 10.1023/A:1015967017103
– volume: 30
  start-page: 379
  year: 2004
  ident: 478_CR37
  publication-title: Semin Thromb Hemost
  doi: 10.1055/s-2004-831051
– volume: 60
  start-page: 237
  year: 2003
  ident: 478_CR1
  publication-title: Occup Environ Med
  doi: 10.1136/oem.60.4.237
– volume: 164
  start-page: 1665
  year: 2001
  ident: 478_CR9
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.164.9.2101036
– volume: 58
  start-page: 31
  year: 2001
  ident: 478_CR18
  publication-title: Occup Environ Med
  doi: 10.1136/oem.58.1.31
– volume: 104
  start-page: 143
  year: 2012
  ident: 478_CR3
  publication-title: Br Med Bull
  doi: 10.1093/bmb/lds028
– volume: 71
  start-page: 2012
  year: 1985
  ident: 478_CR23
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1991.71.5.2012
– reference: 18079100 - Cardiovasc Res. 2008 May 1;78(2):203-12
– reference: 11520795 - Blood. 2001 Sep 1;98(5):1456-63
– reference: 1837015 - J Appl Physiol (1985). 1991 Nov;71(5):2012-8
– reference: 24043436 - Am J Epidemiol. 2013 Nov 1;178(9):1424-33
– reference: 2145819 - Arch Pathol Lab Med. 1990 Oct;114(10):1063-70
– reference: 1849213 - Lung. 1991;169(1):31-42
– reference: 9546745 - J Environ Pathol Toxicol Oncol. 1998;17(2):81-97
– reference: 7449392 - Cor Vasa. 1980;22(4):221-37
– reference: 2156434 - Am J Pathol. 1990 Mar;136(3):695-705
– reference: 23265910 - J Heart Lung Transplant. 2013 Mar;32(3):347-54
– reference: 11238114 - Blood. 2001 Mar 15;97(6):1727-32
– reference: 9603153 - Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1666-80
– reference: 9731009 - Am J Respir Crit Care Med. 1998 Sep;158(3):807-14
– reference: 21761428 - Am J Ind Med. 2011 Oct;54(10):727-33
– reference: 12162431 - Mol Cell Biochem. 2002 May-Jun;234-235(1-2):177-84
– reference: 17351471 - Curr Opin Allergy Clin Immunol. 2007 Apr;7(2):168-73
– reference: 20434368 - J Vasc Interv Radiol. 2010 Jun;21(6):896-902
– reference: 16537877 - Chest. 2006 Mar;129(3):746-52
– reference: 15282661 - Semin Thromb Hemost. 2004 Jun;30(3):379-85
– reference: 23080418 - Br Med Bull. 2012;104:143-61
– reference: 10969041 - Circ Res. 2000 Sep 1;87(5):418-25
– reference: 15863640 - Eur Respir J. 2005 May;25(5):834-42
– reference: 11590839 - Clin Chest Med. 2001 Sep;22(3):433-49, viii
– reference: 25139503 - Cardiovasc Diabetol. 2014 Aug 21;13:119
– reference: 20081107 - Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1235-48
– reference: 8757631 - J Immunol. 1996 Aug 1;157(3):1233-41
– reference: 18403674 - Science. 2008 May 2;320(5876):674-7
– reference: 26699726 - Eur Respir J. 2016 Mar;47(3):876-88
– reference: 11719307 - Am J Respir Crit Care Med. 2001 Nov 1;164(9):1665-8
– reference: 9824081 - Crit Care Med. 1998 Nov;26(11):1868-74
– reference: 11213022 - J Environ Pathol Toxicol Oncol. 2000;19(4):391-400
– reference: 23608224 - Am J Pathol. 2013 May;182(5):1474-81
– reference: 12660371 - Occup Environ Med. 2003 Apr;60(4):237-43
– reference: 7741860 - Lancet. 1995 Jan 21;345(8943):176-8
– reference: 11757635 - Eur Respir J. 2001 Nov;18(5):838-45
– reference: 11119632 - Occup Environ Med. 2001 Jan;58(1):31-7
– reference: 16280974 - MMWR Surveill Summ. 2005 Nov 11;54(5):1-28
SSID ssj0017875
Score 2.3681867
Snippet Background Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and...
Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive...
Background Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 160
SubjectTerms Animal models
Animals
Collagen - metabolism
Development and progression
Extracellular Matrix Proteins - metabolism
Gene Expression Regulation - drug effects
Hemodynamics - drug effects
Histology
Histopathology
Hypertension
Hypertension, Pulmonary - chemically induced
Hypertension, Pulmonary - pathology
Hypertrophy, Right Ventricular - chemically induced
Hypertrophy, Right Ventricular - pathology
Inflammation - chemically induced
Inflammation - pathology
Injections, Spinal
Lung - pathology
Male
Medicine
Medicine & Public Health
Mice
Mice, Inbred C57BL
Muscle, Smooth, Vascular - drug effects
Muscle, Smooth, Vascular - pathology
Physiological aspects
Pneumology/Respiratory System
Pulmonary Fibrosis - chemically induced
Pulmonary Fibrosis - complications
Pulmonary Fibrosis - pathology
Pulmonary hypertension
Risk factors
Silica
Silicon Dioxide - toxicity
Silicosis
Silicosis - pathology
Vascular Remodeling - drug effects
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0gvgifptaZQVBUEKT7EeyT1LEUoSKDy3cW0gmE3pQkjO5A_vfdybZxObAPu8k2czOzsxvZ3ZGiE8OXVEUtQ6dslmotYOwTFCFSV1GkNUIsePLyee_7Nml_rkyK3_g1vu0ykknDoq6aoHPyI8JidhEZ7GOv23-hNw1iqOrvoXGQ_EoJk-EWzekqxlwxSSMZrxdZELnkthHNePMHvds5xhIE57WBKTMwi7ta-c75mk_dXIvfjqYpdNn4qn3J-XJKADPxQNsXojH5z5i_lJc_N5d09SL7kZeEeTshoT1tpFFU8kpC1V2ODTEoQ_IdSO5Qb3Ev5u2x0puWwndDbmQXLsbZb_mQ75X4vL0x8X3s9B3UgjBRmobxqDRpITEtMkq1IWDxKFCpdCAcVWdorKAkePia1WkoVIc_wNCQxkkprDqtTho2gbfCknwJMMEFJDroesyKbG0QF4PYqRqUC4Q0cTHHHyZce52cZ0PcCOz-cj6nFPLmPW5CcSX-ZHNWGPjPuLPvDg57z96LxT-GgHNjitZ5Sea2-4wzgrE0YKS9g0sh6flzf2-7fN_UhaIj_MwP8m5aA22u4FGW9KMaRaIN6M0zNPme8Vk4dNApAs5mQm4mvdypFlfDVW9yfPiwjuB-DpJ1J1p_Y8bh_f_xDvxJGERj-MwyY7Ewbbb4Xtyorblh2Gn3AImlxgx
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9RADA96gvgifls9ZQRBUIpt56Mzj8ficQgnPtzBvZU2TbmFoz26u-D99ybdbtkuKvg8me4wk5nkt0l-AfgYKJRl2Zg4aOdjYwLGVUY6zpoqQd8QpkGKk89_uLNL8_3KXo1k0VILsx-_T737uhJ7JICXca9hwGPvwwPL764o88ItpoAB650dg5Z_nDYzO4eP7571OcyMPAiPDlbn9Ak8Ht1FdbI936dwj9pn8PB8DIg_h4ufmxtWpLK_U9eMKPshH71rVdnWapdkqnoa-t3wD6hlq6T_vKJft92KarXuFPZ37CEKNTep1VL-w3sBl6ffLhZn8dgoIUaX6HWcoiGbM9Ay1tdkyoBZIE1ak0Ub6iYn7ZCSINxqdWKw1hLeQwY7HjNbOv0SjtqupdegGH14ylAjexamqbKKKofs1BAlukEdIkh2-1jgyCIuzSxuigFNeFdst76QzDHZ-sJG8Hmacrul0PiX8Cc5nEKuF38Xy7FKgFcnRFXFiZGuOgKjIjieSfK1wPnw7niL8VquCoazLjM-NWkEH6ZhmSmpZi11m0HGOH74ch_Bq602TMuWsmE24HkE-UxPJgEh656PtMvrgbSbHSvh1Yngy06j9pb1t91481_Sb-FRJhqfpnHmj-Fo3W_oHbtM6-r9cFl-AxU5DtU
  priority: 102
  providerName: Springer Nature
Title Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica
URI https://link.springer.com/article/10.1186/s12931-016-0478-5
https://www.ncbi.nlm.nih.gov/pubmed/27894297
https://www.proquest.com/docview/1846248141
https://www.proquest.com/docview/1844607378
https://pubmed.ncbi.nlm.nih.gov/PMC5126840
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_6AWMvY9_z2gUNBoMNb7Yly_bDGFloKYGWsjWQN2PLZxoIduck0Pz3vZPtrAndYE8GS7bF6Sff_XSnO4APCSZZlpXKTaSOXaUS4-YBSjcoc8_EJRo_4cPJ5xf6bKLG03C6B315q06AiwepHdeTmjTzL7e_199pwX-zCz7WXxess5gUEzdWRIrCfTi07iKO5FN_nAqEzbA9bBS6pJannZPzwVdsqandn_U9bbUbSbnjTrVa6vQpPOnMSzFs8fAM9rB6Do_OOwf6C7i6XM0JeFmzFtfEQBsbv15XIqsK0QeligZtfRz6gJhVguvVC7y9qRdYiGUtTLMmi5JTeaNYzHjP7yVMTk-uRmduV1jBNdqTS9c3CsOIiJkK4wJVlpggQYlSYmjCpCgjlNqgl3AutsJTppDsDjREjmIThJmWr-Cgqit8A4LYSoyBkYYsEVXmQY65NmQEIXqyNDJxwOvlmJou6zgXv5inln3EOm1Fn3KkGYs-DR34tHnkpk258a_OH3lyUgYIvddk3akCGh0ntkqHiqvwMO1y4HirJy0js93cT2_aozAl-qsDFfvKd-D9ppmf5NC0CuuV7aM0_Sij2IHXLRo2w-ZjxqTwIweiLZxsOnBy7-2WanZtk3yTIcZ5eBz43CPq3rD-Jo23_yO6I3gcMOB93w3iYzhYNit8RxbWMh_AfjSNBnA4HI5_jen64-Ti8ifdHenRwO5aDOzKugMOcCTX
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN9kDDASCAkULbGdNH6Y0IBNHVurCXXS3rLEuWiVRtI1raD_HH8bd2lS1krsbc92Eud8vruf7wvgnUGTJEmuXaPCyNXaWDeVqFyZp56NcrS-4eTk_iDsnervZ8HZBvxpc2E4rLKVibWgzkrLd-Q7hERCqSNf-5_HVy53jWLvattCI2laK2S7dYmxJrHjCOe_CMJVu4ffaL_fS3mwP_zac5suA64NPTV1fasx6BJK0UGUoU6MlQYVKoWBDUyWd1GFFj3DhckyT9tMsW_MElKIrAySUNF778Cm5guUDmx-2R-c_Fj6Meg4BIv8psA1RvqNX9WPwp2KNS1DeUL0mqBcsKIZ1_XDNQW5Hry55sGtFePBQ3jQWLRib8GCj2ADi8dwt9_47J_A8GR2ScRLJnNxQaB3UofMl4VIiky0cbBignVLHvqAGBXiJ0kvgb_HZYWZmJbCTuZkxHL1cBTViK8Zn8LprVD5GXSKssAXIAggRSitsmT86DyVKaahJbsL0VO5VcYBr6VjbJtC59xv4zKuAU8UxgvSxxzcxqSPAwc-Lh8ZL6p83DT5A29OzBKA3muTJpGBVse1tOI9zY1_GOk5sL0yk06uXR1utzduJEcV_-NzB94uh_lJjoYrsJzVc3RIsrkbOfB8wQ3LZXNmM9kYXQe6K3yynMD1xFdHitFFXVecbD8u_ePAp5ajri3rf9TYuvkn3sC93rB_HB8fDo5ewn3J7O77roy2oTOdzPAVmXTT9HVzbgSc3_ZR_QuSRlqT
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEF-0heKL-N1o1RUEQQlNsh_ZfTzUo562FGyhbyHZTOhBSY4kB_a_dyZfNIcKPu9ssuzOZOaXmf0NY-8t2DRNC-lboY0vpXV-FoHwoyILnCnAhZYuJ5-e6ZNLubpSV0Of02asdh9Tkv2dBmJpKtvjTV70Jm70cUNeimAwomGJMEjdZ_tGWYvoa3-xWP1cTYkE1Ec1JDP_OHHmjnY_yne80m7F5E7atPNGy0fs4RBG8kV_7o_ZPSifsIPTIVH-lF2cb29QwdL6ll8j0qy7OvWq5GmZ87H4lNfQ9cHBF_B1yakvPYdfm6qBnLcVd_UtRo5E2Q28WdO_vWfscvn14vOJPzRQ8J0OROuHToKKEYBJZXKQqXWRBQFCgHLK5kUMQjsILHGu5YF0uaC0n0MQZFykUi2es72yKuGQcUQlBiInHEYcssiiDDLtMNgBCEThhPVYMO5j4gZ2cWpycZN0KMPopN_6hCrKaOsT5bGP05RNT63xL-EPdDgJmR0-16XD7QFcHRFYJQtJ3XYIXnnsaCaJ5uLmw-PxJoO5NgnCXB1JE8rQY--mYZpJJWglVNtORmr8IMbGYy96bZiWTdeJ0bHHHotnejIJEIn3fKRcX3dk3hhwEd-Oxz6NGnVnWX_bjZf_Jf2WHZx_WSY_vp19f8UeRKT8YehH5ojttfUWXmNU1WZvBsv5DRC6G4I
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pulmonary+hypertension+and+vascular+remodeling+in+mice+exposed+to+crystalline+silica&rft.jtitle=Respiratory+research&rft.au=Zelko%2C+Igor+N.&rft.au=Zhu%2C+Jianxin&rft.au=Ritzenthaler%2C+Jeffrey+D.&rft.au=Roman%2C+Jesse&rft.date=2016-11-28&rft.issn=1465-993X&rft.eissn=1465-993X&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs12931-016-0478-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12931_016_0478_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon